- Home
- Publications
- Publication Search
- Publication Details
Title
Update on current and potential nanoparticle cancer therapies
Authors
Keywords
-
Journal
CURRENT OPINION IN ONCOLOGY
Volume 25, Issue 6, Pages 646-651
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-10-07
DOI
10.1097/cco.0000000000000012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles
- (2015) Mian M.K. Shahzad et al. NEOPLASIA
- Theranostic Nanoparticles with Controlled Release of Gemcitabine for Targeted Therapy and MRI of Pancreatic Cancer
- (2013) Gee Young Lee et al. ACS Nano
- pH-Responsive Assembly of Gold Nanoparticles and “Spatiotemporally Concerted” Drug Release for Synergistic Cancer Therapy
- (2013) Jutaek Nam et al. ACS Nano
- Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis
- (2013) Shixian Huang et al. ACS Nano
- Targeted Nanoparticles Assembled via Complexation of Boronic-Acid-Containing Targeting Moieties to Diol-Containing Polymers
- (2013) Han Han et al. BIOCONJUGATE CHEMISTRY
- Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
- (2013) Mark Katakowski et al. CANCER LETTERS
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
- (2013) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Nanoparticle Delivered Vascular Disrupting Agents (VDAs): Use of TNF-Alpha Conjugated Gold Nanoparticles for Multimodal Cancer Therapy
- (2013) Mithun M. Shenoi et al. MOLECULAR PHARMACEUTICS
- Therapeutic nanoparticles in clinics and under clinical evaluation
- (2013) Catherine A Schütz et al. Nanomedicine
- Biomimetic, synthetic HDL nanostructures for lymphoma
- (2013) S. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
- (2013) D. T. Wiley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics
- (2013) G. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection
- (2012) Zeyu Xiao et al. ACS Nano
- Nanosized Multifunctional Polyplexes for Receptor-Mediated SiRNA Delivery
- (2012) Christian Dohmen et al. ACS Nano
- Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery
- (2012) Marina G. Damiano et al. ADVANCED DRUG DELIVERY REVIEWS
- A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer
- (2012) Peter J. Hosein et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial
- (2012) Ó Arrieta et al. BRITISH JOURNAL OF CANCER
- Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study
- (2012) David S. Alberts et al. GYNECOLOGIC ONCOLOGY
- Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type
- (2012) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated Liposomal Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone in AIDS-Related Lymphoma: AIDS Malignancy Consortium Study 047
- (2012) Alexandra M. Levine et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: In vitro and in vivo studies
- (2012) Hongfang Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Reductively Responsive siRNA-Conjugated Hydrogel Nanoparticles for Gene Silencing
- (2012) Stuart S. Dunn et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antibody-Linked Spherical Nucleic Acids for Cellular Targeting
- (2012) Ke Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles
- (2012) Pedro M Valencia et al. Nanomedicine
- Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
- (2012) Hyukjin Lee et al. Nature Nanotechnology
- Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation
- (2012) Dan Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4
- (2012) Y. Ren et al. Science Translational Medicine
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Tailoring of Biomimetic High-Density Lipoprotein Nanostructures Changes Cholesterol Binding and Efflux
- (2011) Andrea J. Luthi et al. ACS Nano
- The role of iron in tumour cell proliferation
- (2011) Juan Luis Steegmann-Olmedillas Clinical & Translational Oncology
- A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study
- (2011) Robert L. Coleman et al. GYNECOLOGIC ONCOLOGY
- Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo
- (2011) Justin B. Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Biomimetic High Density Lipoprotein Nanoparticles For Nucleic Acid Delivery
- (2011) Kaylin M. McMahon et al. NANO LETTERS
- Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
- (2011) Warefta Hasan et al. NANO LETTERS
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
- (2010) S. K. Libutti et al. CLINICAL CANCER RESEARCH
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Clinical Developments in Nanotechnology for Cancer Therapy
- (2010) Jeremy D. Heidel et al. PHARMACEUTICAL RESEARCH
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Nanotechnology and Cancer
- (2007) James R. Heath et al. Annual Review of Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search